StrideAI

StrideAI is developing a Smart Insole and a Smart Shoe on a shared sensing core that measures plantar pressure, bilateral foot temperature, movement, and gait outside the clinic. The platform targets sport, defense, and healthcare, with a proposed recurring clinical monitoring model. Three prototype generations have been built, and US utility and PCT patent applications were filed in July 2026. StrideAI is raising seed capital for engineering, validation, and a planned FDA submission. Its products are in development and have not been cleared or approved by the FDA; clinical evidence cited in the brief comes from studies of other devices.